PMAM
ADMA icon

Picton Mahoney Asset Management’s ADMA Biologics ADMA Stock Holding History

Picton Mahoney Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577 Sell
64
-230,752
-100% -$3.64M ﹤0.01% 1225
2025
Q4 		$4.21M Sell
230,816
-133,222
-37% -$2.25M 0.05% 353
2025
Q3 		$5.34M Sell
364,038
-73,679
-17% -$1.26M 0.07% 270
2025
Q2 		$7.97M Buy
437,717
+305,149
+230% +$6.22M 0.11% 217
2025
Q1 		$2.63M Buy
132,568
+132,504
+207,038% +$2.29M 0.09% 227
2024
Q4 		$1K Sell
64
-2,800
-98% -$52.7K ﹤0.01% 596
2024
Q3 		$57K Buy
+2,864
New +$44.5K ﹤0.01% 368

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return